An Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Subjects
Metabolic Syndrome, Insulin Resistance, Overweight
About this trial
This is an interventional prevention trial for Metabolic Syndrome focused on measuring Cardiometabolic risk, Diet, Dietary prevention, Functional diet, Functional foods, Metabolic Syndrome, Overweight
Eligibility Criteria
Inclusion Criteria:
- Normal fasting blood glucose (max 6.1 mmol /l)
- BMI between 25 and 32 Kg/m2
Exclusion Criteria:
- treatment for hypercholesterolemia
- treatment for hypertension
- history of cardiovascular complications
Sites / Locations
- Functional Food Science Centre. Lund University Medicon Village
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Multifunctional diet (MFD)
Control diet
Subjects eat a diet designed according to the Nordic Nutrition Recommendations with the addition of important amounts of various functional food concepts: Low GI and GI-modulating food items; Natural antioxidant-rich items, Long chain omega-3 fatty acid-rich fish; Betaglucan-rich barley and oat food/drinks; Cholesterol-modulating foods.
Subjects eat a diet designed according to the Nordic Nutrition Recommendations but lacking the functional items included in the MFD.